Raymond James Financial Services Advisors, Inc. Regenxbio Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 64,338 shares of RGNX stock, worth $445,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,338

Previous 62,443 3.03%

Holding current value

$445,862

Previous $730,000 7.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$10.49 - $14.39 $19,878 - $27,269	1,895 Added 3.03%	64,338 $674,000
Q2 2024 Jul 19, 2024	BUY	$11.51 - $21.53 $59,403 - $111,116	5,161 Added 9.01%	62,443 $730,000
Q1 2024 Apr 22, 2024	SELL	$12.17 - $24.61 $104,917 - $212,162	-8,621 Reduced 13.08%	57,282 $1.21 Million
Q4 2023 Jan 16, 2024	SELL	$12.89 - $20.82 $632,370 - $1.02 Million	-49,059 Reduced 42.67%	65,903 $1.18 Million
Q3 2023 Oct 24, 2023	BUY	$16.46 - $19.99 $823,921 - $1 Million	50,056 Added 77.12%	114,962 $1.89 Million
Q2 2023 Jul 25, 2023	BUY	$17.23 - $21.71 $398,340 - $501,913	23,119 Added 55.33%	64,906 $1.3 Million
Q1 2023 Apr 14, 2023	SELL	$18.08 - $24.55 $42,487 - $57,692	-2,350 Reduced 5.32%	41,787 $790,000
Q4 2022 Feb 08, 2023	SELL	$20.4 - $24.73 $220,279 - $267,034	-10,798 Reduced 19.66%	44,137 $1 Million
Q3 2022 Oct 25, 2022	SELL	$22.29 - $35.04 $28,063 - $44,115	-1,259 Reduced 2.24%	54,935 $1.45 Million
Q2 2022 Aug 12, 2022	SELL	$19.35 - $35.04 $63,893 - $115,702	-3,302 Reduced 5.55%	56,194 $1.39 Million
Q1 2022 May 11, 2022	BUY	$24.62 - $34.31 $240,414 - $335,037	9,765 Added 19.64%	59,496 $1.98 Million
Q4 2021 Feb 08, 2022	BUY	$30.19 - $40.28 $29,827 - $39,796	988 Added 2.03%	49,731 $1.63 Million
Q3 2021 Nov 02, 2021	BUY	$29.09 - $45.68 $205,433 - $322,592	7,062 Added 16.94%	48,743 $2.04 Million
Q2 2021 Aug 11, 2021	BUY	$32.46 - $40.48 $485,796 - $605,823	14,966 Added 56.02%	41,681 $1.62 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $897,891 - $1.33 Million	26,715 New	26,715 $911,000
Q1 2020 Apr 21, 2020	SELL	$21.5 - $54.2 $268,707 - $677,391	-12,498 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$34.54 - $44.87 $324,848 - $422,002	-9,405 Reduced 42.94%	12,498 $512,000
Q3 2019 Nov 07, 2019	SELL	$31.84 - $50.88 $112,236 - $179,352	-3,525 Reduced 13.86%	21,903 $780,000
Q2 2019 Aug 06, 2019	BUY	$42.0 - $59.29 $451,626 - $637,545	10,753 Added 73.27%	25,428 $1.31 Million
Q1 2019 May 06, 2019	BUY	$40.82 - $62.45 $224,142 - $342,912	5,491 Added 59.79%	14,675 $841,000
Q4 2018 Feb 11, 2019	BUY	$39.11 - $75.15 $175,134 - $336,521	4,478 Added 95.16%	9,184 $385,000
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $305,890 - $386,597	4,706 New	4,706 $355,000

Others Institutions Holding RGNX

# of Institutions

191

Shares Held

45.4M

Call Options Held

184K

Put Options Held

56.7K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $300M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Regenxbio Inc. Transaction History